Skip to main content
Reimbursement strategy

Market Access Strategy for Medical Devices in Europe

Strategic recommendations on the topic of market access pathways for medical devices and IVD tests

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Forty-five applications for innovation funding for healthcare research projects were accepted in Germany

On June 9, 2026, the Innovation Committee at the Federal Joint Committee (G-BA) announced that forty-five applications for innovation funding of healthcare research projects were accepted.

The examples of topics the applications were submitted for are provided below:

  • Promoting transplant medicine care – analyzing the identification and reporting of potential post-mortem organ donors in hospitals and deriving recommendations for action: 3;
  • Care for patients with post-viral symptom complexes such as post/long-term COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): 3;
  • Health services research to improve the care of individuals with ophthalmologic diseases: 2;
  • Open topic: 20.

In total, the Innovation Committee received 268 applications for its two funding announcements (topic-specific and open-topic) of June 20, 2025. 112 of these related to the topic-specific funding announcement, 56 to the open-topic announcement. In evaluating the applications, the Innovation Committee considered the recommendations of its advisory panel, the so-called Expert Pool.

This news is just one of about 300 market access news collected by our team in the premium subscription service MTRC Access Intelligence every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.